Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Quadrivalent Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03564444
What this trial is testing

D2560C00015 FluMist Annual Safety Study 2018

Who this might be right for
InfluenzaHealthy
MedImmune LLC 300
Post-approval studies (Phase 4)Study completedNCT02473510
What this trial is testing

Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season

Who this might be right for
InfluenzaHealthy
MedImmune LLC 301
Testing effectiveness (Phase 2)Study completedNCT04192500
What this trial is testing

Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years

Who this might be right for
Influenza
Osivax 300
Large-scale testing (Phase 3)Study completedNCT02467842
What this trial is testing

Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects

Who this might be right for
Influenza
SK Chemicals Co., Ltd. 1,503
Post-approval studies (Phase 4)Study completedNCT04790851
What this trial is testing

Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4

Who this might be right for
Influenza, HumanPneumonia, PneumococcalCovid19
China National Biotec Group Company Limited 1,133
Large-scale testing (Phase 3)Study completedNCT03020628
What this trial is testing

Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months

Who this might be right for
Influenza, Human
SK Chemicals Co., Ltd. 171
Testing effectiveness (Phase 2)Study completedNCT02480998
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of 'IL-YANG Flu Vaccine Quadrivalent Inj' in Healthy Korean Adults

Who this might be right for
Influenza, Human
Il-Yang Pharm. Co., Ltd. 84
Large-scale testing (Phase 3)Study completedNCT03301051
What this trial is testing

Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults

Who this might be right for
Virus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+2 more
Medicago 10,160
Post-approval studies (Phase 4)UnknownNCT05389137
What this trial is testing

To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years

Who this might be right for
Influenza
Wuhan Institute of Biological Products Co., Ltd 360
Post-approval studies (Phase 4)Ended earlyNCT03023709
What this trial is testing

Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032)

Who this might be right for
Influenza
Stanford University 3
Large-scale testing (Phase 3)Study completedNCT05645900
What this trial is testing

A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months

Who this might be right for
Influenza
Ab&B Bio-tech Co., Ltd.JS 2,772
Post-approval studies (Phase 4)Study completedNCT05138705
What this trial is testing

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years

Who this might be right for
Influenza, Human
Shanghai Institute Of Biological Products 380
Post-approval studies (Phase 4)Study completedNCT03722589
What this trial is testing

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

Who this might be right for
Influenza
Centers for Disease Control and Prevention 944
Large-scale testing (Phase 3)Study completedNCT02366962
What this trial is testing

Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older

Who this might be right for
InfluenzaVaccine
UMN Pharma Inc. 55
Testing effectiveness (Phase 2)Study completedNCT04969276
What this trial is testing

Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 306
Large-scale testing (Phase 3)Study completedNCT02290509
What this trial is testing

Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age

Who this might be right for
Influenza
Protein Sciences Corporation 1,350
Large-scale testing (Phase 3)Study completedNCT06385821
What this trial is testing

Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

Who this might be right for
InfluenzaInfluenza AInfluenza, Human+8 more
NPO Petrovax 824
Testing effectiveness (Phase 2)Study completedNCT04622592
What this trial is testing

Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older

Who this might be right for
Influenza
Medicago 209
Early research (Phase 1)Study completedNCT03945825
What this trial is testing

Flublok or Fluzone With Advax-CpG55.2 or AF03

Who this might be right for
InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 241
Post-approval studies (Phase 4)UnknownNCT05079152
What this trial is testing

Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4

Who this might be right for
Influenza, HumanPneumonia, PneumococcalCOVID-19 Pneumonia
China National Biotec Group Company Limited 1,404
Next Page